[1]
“AI-Driven Assessment of The Efficacy And Safety of Gene and Cell-Based Therapies for Ischemic Heart Disease: A Systematic Review of Clinical Trials”, JOC, vol. 23, no. 1, pp. 1065–1078, Dec. 2024, doi: 10.66838/J.Carcinog.23.1.1065-1078.